Anti-transcriptional intermediary factor 1-γ antibody is a useful serum marker for cancer-associated myositis
10.3760/cma.j.issn.1007-7480.2013.01.003
- VernacularTitle:血清抗转录中介因子1-γ抗体在多发性肌炎/皮肌炎合并肿瘤诊断中的价值
- Author:
Hanbo YANG
;
Xiaoming SHU
;
Qinglin PENG
;
Yan WANG
;
Guochun WANG
;
Xin LU
- Publication Type:Journal Article
- Keywords:
Polymyositis;
Dermatomyositis;
Neoplasms,second primary;
Anti-transcriptional intermediary factor 1-γ antibody
- From:
Chinese Journal of Rheumatology
2013;(1):10-15
- CountryChina
- Language:Chinese
-
Abstract:
Objective To identify the prevalence of anti-transcriptional intermediary factor (TIF)1-γ antibody in Chinese patients with idiopathic inflammatory myositis and to define its role in the assessment of early diagnosis of cancer associated myositis (CAM) in a large cohort.Methods Sera from 96 Chinese patients with dermatomyositis(DM),50 patients with polymyositis (PM),33 patients with systemic lupus erythem-atosus (SLE),54 patients with rheumatoid arthritis (RA),8 patients with systemic sclerosis (SSc),and 40 healthy controls were examined by immunoprecipitation assays followed by Western blotting.The distribution of these antibodies in each group was assessed and the association between this autoantibody and CAM in a large cohort was further revealed.T test,Mann-Wittney U test,Chi-square test and Fisher exact test were used for statistical analysis.Results Sera from 17 of 96 DM patients (18%),including 1 with juvenile dermatomyositis (JDM) (17%),2 with clinical amyopathic dermatomyositis (CADM) (25%),and 9 with CAM (64%) were found to have anti-TIF1-γ antibody by immunoprecipitation assays followed by Western blotting.Only 1 patient with PM (2%) was observed with anti-TIF1-γ autoantibody,and no patients with other connective tissue disease patients as well as healthy controls were positive for this autoantibody.The risk of -developing CAM in anti-TIF1γ-positive patients was significantly increased compared to the anti-TIF1-γnegative group,with an OR of 17.74 (95%CI,5.68-55.40).In DM,the negative and positive predictive value of anti-TIF1-γ autoantibody for the diagnosis of CAM was 90.8% and 56.3%,respectively.Anti-TIF1γ-positive DM patients were significantly older than anti-TIF1-γ-negative DM patients (63±11 vs 48 ±14,P<0.01).Notably,three of the anti-TIF1γ-positive patients had ILD,one patient was classified as having CAM and the other two were DM patients without cancer,but anti-TIF1γ-positive patients still had a significantly lower incidence of interstitial lung disease (19% vs 54%,P<0.05).In contrast to anti-TIF1-γγ-negative DM patients,anti-TIF1-γ antibody-positive patients were more frequently (81% vs 50%,P<0.01).There was no significant difference between these groups in terms of other clinical and laboratory parameters.Conclusion Anti-TIF1-γ antibodies may act as a useful diagnostic serological marker for early diagnosis of CAM in Chinese patients.For patients with DM,anti-TIF1-γ antibodies should be assessed at the time of disease diagnosis.This antibody may have impo-rtant significance in the early diagnosis of tumor and improving prognosis.